Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pier Francesco Bassi

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Clinical Genitourinary Cancer|December 29, 2015
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature ReviewRiccardo Bientinesi, Mauro Ragonese, Francesco Pinto, et al.
Urology|April 5, 2008
Renal hemangiopericytoma: case report and review of the literatureAntonio Brescia, Francesco Pinto, Mario Gardi, et al.
Urologia|October 21, 2015
NBI: results reviewMarco Racioppi, Daniele D'Agostino, Mauro Ragonese, et al.
Urologia|December 3, 2014
[Urinary tract infections.]Nazario Foschi, Riccardo Bientinesi, Giuseppe Palermo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 21, 2016
K<sub>V</sub>7 channels in the human detrusor: channel modulator effects and gene and protein expressionRiccardo Bientinesi, Cesare Mancuso, Maria Martire, et al.
Urologia|April 1, 2011
[Circumcision: history, religion and law]Angelo Totaro, Andrea Volpe, Marco Racioppi, et al.
Urologic Oncology|December 5, 2009
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort studyPier Francesco Bassi, Luca Bongiovanni, Marco Racioppi, et al.
World Journal of Surgery|December 22, 2005
Successful repair of iatrogenic rectourinary fistulas using the posterior sagittal transrectal approach (York-Mason): 15-year experienceFabrizio Dal Moro, Mariangela Mancini, Francesco Pinto, et al.
BMC Cancer|December 8, 2018
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomesMarco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 21, 2019
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Clinical Genitourinary Cancer|December 29, 2015
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature ReviewRiccardo Bientinesi, Mauro Ragonese, Francesco Pinto, et al.
Urology|April 5, 2008
Renal hemangiopericytoma: case report and review of the literatureAntonio Brescia, Francesco Pinto, Mario Gardi, et al.
Urologia|October 21, 2015
NBI: results reviewMarco Racioppi, Daniele D'Agostino, Mauro Ragonese, et al.
Urologia|December 3, 2014
[Urinary tract infections.]Nazario Foschi, Riccardo Bientinesi, Giuseppe Palermo, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 21, 2016
K<sub>V</sub>7 channels in the human detrusor: channel modulator effects and gene and protein expressionRiccardo Bientinesi, Cesare Mancuso, Maria Martire, et al.
Urologia|April 1, 2011
[Circumcision: history, religion and law]Angelo Totaro, Andrea Volpe, Marco Racioppi, et al.
Urologic Oncology|December 5, 2009
Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort studyPier Francesco Bassi, Luca Bongiovanni, Marco Racioppi, et al.
World Journal of Surgery|December 22, 2005
Successful repair of iatrogenic rectourinary fistulas using the posterior sagittal transrectal approach (York-Mason): 15-year experienceFabrizio Dal Moro, Mariangela Mancini, Francesco Pinto, et al.
BMC Cancer|December 8, 2018
ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk "BCG failure" non muscle invasive bladder cancer: 3 years follow-up outcomesMarco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|February 21, 2019
Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?Marco Racioppi, Luca Di Gianfrancesco, Mauro Ragonese, et al.
Pageof 7